Cite us – Covid Guidelines India

CITATIONS

Anti-coagulation

Covid Management Guidelines India Group – Anticoagulation Working Group. Prophylactic Vs Therapeutic dose anticoagulation. Covid Guidelines India; Published online on June 9, 2021; URL: https://indiacovidguidelines.org/anti-coagulation/ (accessed <date>).

Ivermectin

Covid Management Guidelines India Group – Anti-viral Working Group. Ivermectin. Covid Guidelines India; Published online on May 15, 2021; URL: https://indiacovidguidelines.org/ivermectin/ (accessed <date>).

Remdesivir

Covid Management Guidelines India Group – Anti-viral Working Group. Remdesivir. Covid Guidelines India; Published online on June 1, 2021; URL: https://indiacovidguidelines.org/remdesivir/ (accessed <date>).

Favipiravir

Covid Management Guidelines India Group – Anti-viral Working Group. Favipiravir. Covid Guidelines India; Published online on July 19, 2021; URL: https://indiacovidguidelines.org/favipiravir/ (accessed <date>).

Tocilizumab

Covid Management Guidelines India Group – Anti-inflammatory Working Group. Tocilizumab. Covid Guidelines India; Published online on May 24, 2021; URL: https://indiacovidguidelines.org/tocilizumab/ (accessed <date>).

Inhaled Corticosteroids

Covid Management Guidelines India Group – Anti-inflammatory Working Group. Inhaled Corticosteroids. Covid Guidelines India; Published online on June 21, 2021; URL: https://indiacovidguidelines.org/inhaled-corticosteroids/ (accessed <date>).

Systemic Corticosteroids

Covid Management Guidelines India Group – Anti-inflammatory Working Group. Systemic Corticosteroids. Covid Guidelines India; Published online on July 15, 2021; URL: https://indiacovidguidelines.org/systemic-corticosteroids/ (accessed <date>).

Non-Invasive Ventilation (Niv) Vs High Flow Nasal Oxygen (Hfno)

Covid Management Guidelines India Group – Respiratory Therapy Working Group. Non-Invasive Ventilation (NIV) Vs High Flow Nasal Oxygen (HFNO). Covid Guidelines India; Published online on July 27, 2021; URL :- https://indiacovidguidelines.org/niv-vs-hfno/ (accessed <date>).

Casirivimab – Imdevimab for patients with mild COVID-19

Covid Management Guidelines India Group – Anti-body Working Group. Casirivimab – Imdevimab. Covid Guidelines India; Published online on August 11, 2021; URL : https://indiacovidguidelines.org/casirivimab-and-imdevimab-regn-covtm/ (accessed <date>).

Casirivimab – Imdevimab (REGEN-COV™) for hypoxic patients with moderate, severe or critical COVID-19

Casirivimab Imdevimab – Asymptomatic

Covid Management Guidelines India Group – Anti-body Working Group. Casirivimab – Imdevimab. Covid Guidelines India; Published online on August 27, 2021; URL : https://indiacovidguidelines.org/casirivimab-imdevimab-asymptomatic/ (accessed <date>).

Colchicine

Covid Management Guidelines India Group – Anti-inflammatory working Group – Colchicine. Covid Guidelines India; Published online on September 03rd , 2021; URL:https://indiacovidguidelines.org/colchicine/ (accessed <date>).

Baricitinib

Covid Management Guidelines India Group – Anti-inflammatory working Group – Baricitinib. Covid Guidelines India; Published online on September 17th, 2021; URL: https://indiacovidguidelines.org/baricitinib/ accessed <date>).

Azithromycin

Covid Management Guidelines India Group – Anti-inflammatory working Group – Azithromycin. Covid Guidelines India; Published online on September 27th, 2021; URL: https://indiacovidguidelines.org/azithromycin/ accessed <date>).

Convalescent Plasma

Covid Management Guidelines India Group – Antibody working Group – Convalescent Plasma. Covid Guidelines India; Published online on 27th October 2021; URL: https://indiacovidguidelines.org/convalescent-plasma/ (accessed <date>)

Prone Positioning

Covid Management Guidelines India Group – Other Supportive Management Working Group. Prone Positioning. Covid Guidelines India; Published online on November 05th, 2021; URL: https://indiacovidguidelines.org/prone-positioning/ (accessed <date>)

Itolizumab

Covid Management Guidelines India Group – Anti-inflammatory working Group – Itolizumab. Covid Guidelines India; Published online on November 22nd, 2021; URL: https://indiacovidguidelines.org/itolizumab/ accessed <date>).

Sarilumab

Covid Management Guidelines India Group – Anti-inflammatory working Group – Sarilumab. Covid Guidelines India; Published online on November 29th, 2021; URL: https://indiacovidguidelines.org/sarilumab/ accessed <date>).

Hydroxychloroquine / Chloroquine

Covid Management Guidelines India Group – Anti-Viral working Group – Hydroxychloroquine / Chloroquine. Covid Guidelines India; Published online on February 04th, 2022; URL: https://indiacovidguidelines.org/hydroxychloroquine/ (accessed <date>).

Oxygen Saturation Targets

Covid Management Guidelines India Group – Respiratory Therapy Working Group – Oxygen Saturation Targets. Covid Guidelines India; Published online on February 14th, 2022; URL: https://indiacovidguidelines.org/oxygen-saturation-targets/ accessed <date>).

Molnupiravir

Covid Management Guidelines India Group – Anti-Viral Working Group – Molnupiravir. Covid Guidelines India; Published online on February 16th, 2022; URL: https://indiacovidguidelines.org/molnupiravir/ (accessed<date>)

Interferon

Covid Management Guidelines India Group – Anti-Viral Working Group – Interferon. Covid Guidelines India; Published online on March 21st, 2022; URL: https://indiacovidguidelines.org/interferon/ (accessed <date>)

Remdesivir